UserWiki:David Hedlund/Issues

From PsychonautWiki
Jump to: navigation, search

I have listed a few issue here because I'm not sure if they should be ignore or not, and I don't want to bother people in the channel. Please remove the tasks from this page if you finish them, or leave a comment with a preceding signature on each question.

General - Team

Dependence

Subjective effects

Should the property `Effect::Ego inflation` be added to:

Cacti

Ketamine

2C-P

"2C-P is known to have a steep dose-response curve, with a very small margin separating a manageable dose and an overdose." - https://www.erowid.org/chemicals/2cp/2cp_dose.shtml

"There was one report of an experience in which a single dosage of 16 mg was clearly an overdose, with the entire experiment labeled a physical disaster, not to be repeated. A consistent observation is that there may not be too much latitude in dosage between that which would be modest, or adequate, and that which would be excessive. The need for individual titration would be most important with this compound." - PiHKAL, https://isomerdesign.com/PiHKAL/read.php?id=36

MDMA

“Now I would advise anyone who wants to use MDMA not to take it more than 4 times a year if you want to continue to get the best effects from it, otherwise you risk losing its effects entirely and permanently.” - Ann Shulgin

Cannabidiol

https://psychonautwiki.org/wiki/Talk:Cannabidiol

CBD does not appear to have any intoxicating effects such as those caused by tetrahydrocannabinol (THC) in marijuana, but may have a downregulating impact on disordered thinking and anxiety.[1]

https://psychonautwiki.org/wiki/Talk:Cannabidiol#Legal_status CBD does not appear to have any psychoactive ("high") effects such as those caused by ∆9-THC in marijuana, but may have anti-anxiety and anti-psychotic effects.[1] As the legal landscape and understanding about the differences in medical cannabinoids unfolds, it will be increasingly important to distinguish "medical marijuana" (with noted varying degrees of psychotropic effects and deficits in executive function) – from "medical CBD".[1]

MAOI

Can we copy/modify some content from https://en.wikipedia.org/wiki/MAOI#Interactions to https://psychonautwiki.org/wiki/MAOI#Interactions ?

Responsible_drug_use

Add to https://psychonautwiki.org/wiki/Responsible_drug_use under "Reagent testing kits" [proof-read]

Test results for all drugs & substances - https://www.reddit.com/r/ReagentTesting/wiki/nps#wiki_reagent_test_results

File:Packet of 4BDF powder.jpg
4BDF powder. The pink color is most likely due to an impurity. The color of pure BDF is usually white to off-white, similar to most recreational drugs, so there is no way to distinguish between them by eye.[Controversial]

Most pure chemicals are white to off-white so there is no way to distinguish between them by eye. Discoloration is often due to an impurity. The chemicals can still be contaminated with other white chemicals though.

Minor issues

Site content - Clarity

Including special pages.

  • Replace `lucid dreaming` with `Oneironautics``in "documenting all aspects of psychonautics (including practices like meditation, lucid dreaming" at the main page?
  • Please change "Youtube" to "YouTube" in the left pane.
  • I suggest that we rename the gift "DMT Entity" to "Changa". What do you think?

Chemistry - BronzeManul

Kenan trust your chemical knowledge, can you please mention that you. https://psychonautwiki.org/wiki/PsychonautWiki says "Bronzemaul.png BronzeManul (Benjamin): This user is our volunteer for contributing a variety of minor edits, minor edits and more minor edits. They have a large amount of experience and knowledge within this field." Can you please ask Kenan to add that something about your knowledge in chemistry, so people know that they can ask you in the channel? Example: "This user is our volunteer for contributing a variety of content and articles regarding chemistry..."

Base structures

https://psychonautwiki.org/wiki/Category:Base_Structures

Uncategorized

Botanical and mycological - nami

Subjective effect index (SEI) - Josikins

See also

  • 1.0 1.1 1.2 Iseger TA, Bossong MG (2015). "A systematic review of the antipsychotic properties of cannabidiol in humans". Schizophr. Res. 162 (1–3): 153–61. doi:10.1016/j.schres.2015.01.033. PMID 25667194. 
  • Retrieved from ‘https://psychonautwiki.org/w/index.php?title=UserWiki:David_Hedlund/Issues&oldid=115873